Evidence map›Paper›PMID 25520617›Full record

ReviewFrontiers in molecular neuroscience2014

Local ubiquitin-proteasome-mediated proteolysis and long-term synaptic plasticity.

Ashok N Hegde, Kathryn A Haynes, Svitlana V Bach, Brenna C Beckelman

Abstract readReview
In one paragraph

Review in Frontiers in molecular neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. The proteasome regulator PI31 is required for protein homeostasis, synapse maintenance, and neuronal survival in mice.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. TheJournal of cell science · 2017
    Article
  19. Article
  20. Proteolysis, synaptic plasticity and memory.Neurobiology of learning and memory · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ashok N HegdeDepartment of Neurobiology and Anatomy, Wake Forest University Health Sciences Winston-Salem, NC, USA.
Kathryn A HaynesDepartment of Neurobiology and Anatomy, Wake Forest University Health Sciences Winston-Salem, NC, USA.
Svitlana V BachDepartment of Neurobiology and Anatomy, Wake Forest University Health Sciences Winston-Salem, NC, USA.
Brenna C BeckelmanDepartment of Neurobiology and Anatomy, Wake Forest University Health Sciences Winston-Salem, NC, USA.

Funding

Local Mechanisms Underlying Synaptic PlasticityR01NS066583 · NINDS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HEGDE, ASHOK N · 2009 to 2012
$1.3M
A Novel Strategy for Treating Memory Impairment in an Alzheimer's Disease ModelR21AG040975 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HEGDE, ASHOK N · 2012 to 2013
$385k
NIA NIH HHS R21 AG040975NINDS NIH HHS R01 NS066583
6 · The paper itself

Abstract

The ubiquitin-proteasome pathway (UPP) of protein degradation has many roles in synaptic plasticity that underlies memory. Work on both invertebrate and vertebrate model systems has shown that the UPP regulates numerous substrates critical for synaptic plasticity. Initial research took a global view of ubiquitin-protein degradation in neurons. Subsequently, the idea of local protein degradation was proposed a decade ago. In this review, we focus on the functions of the UPP in long-term synaptic plasticity and discuss the accumulated evidence in support of the idea that the components of the UPP often have disparate local roles in different neuronal compartments rather than a single cell-wide function.

Indexed as

learning and memoryproteasomeprotein degradationubiquitinubiquitin conjugation

Identifiers

PMID25520617
PMCPMC4248836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.